HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924

Paul Haluska(Mayo Clinic), Charles Erlichman(Mayo Clinic)
Molecular Cancer Therapeutics
September 1, 2008
Cited by 101


Related Papers